Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Social and Anxiety-Like Behaviors Are Affected in Juvenile Mice With Gli2<sup>+/-</sup> but Not Gli3<sup>+/𝛥699</sup> Genetic Modifications.

Brain and behavior·2026

Same author

Affiliative behavioural phenotype and microglial activation predict social decision-making following immune activation.

Behavioural brain research·2026

Same author

The role of health behaviors in links between stress and epigenetic aging.

Brain, behavior, & immunity - health·2026

Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Exploring diversity: a review of animal models for investigating variations in sex characteristics.

Frontiers in pediatrics·2025

Same author

Cortisol, DHEAS, and the cortisol/DHEAS ratio as predictors of epigenetic age acceleration.

Biogerontology·2025

Same journal

Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

Brain research·2026

Same journal

Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research·2026

Same journal

Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

Brain research·2026

Same journal

Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

Brain research·2026

Same journal

Emotions, the amygdala, and the right hemisphere.

Brain research·2026

Same journal

Electroacupuncture treatment enhances hippocampal growth hormone level and restores mitochondrial function in vascular dementia rats.

Brain research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 5, 2026

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Published on: April 23, 2015

MeCP2 regulates GFAP expression within the developing brain.

Robin M Forbes-Lorman¹, Joseph R Kurian², Anthony P Auger³

¹Department of Psychology, 1202 West Johnson Street, University of Wisconsin-Madison, Madison, WI 53706-1969, USA.

|November 26, 2013

Summary

This summary is machine-generated.

Reducing MeCP2 (methyl CpG binding protein 2) in young female rats increased glial fibrillary acidic protein (GFAP) expression. This effect was specific to GFAP and temporary, highlighting sex-specific gene regulation in the developing brain.

Keywords:

Development GFAP MeCP2 Sex differences

More Related Videos

Isolation of Distinct Cell Populations from the Developing Cerebellum by Microdissection

Isolation of Distinct Cell Populations from the Developing Cerebellum by Microdissection

Published on: September 21, 2014

Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models

Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models

Published on: January 12, 2015

Related Experiment Videos

Last Updated: May 5, 2026

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Viral-mediated Labeling and Transplantation of Medial Ganglionic Eminence MGE Cells for In Vivo Studies

Published on: April 23, 2015

Isolation of Distinct Cell Populations from the Developing Cerebellum by Microdissection

Isolation of Distinct Cell Populations from the Developing Cerebellum by Microdissection

Published on: September 21, 2014

Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models

Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models

Published on: January 12, 2015

Area of Science:

Neuroscience
Developmental Biology
Genetics

Background:

Mutations in the MECP2 gene cause Rett syndrome (RTT), a neurodevelopmental disorder predominantly affecting females.
Individuals with RTT exhibit elevated glial fibrillary acidic protein (GFAP) expression in the brain.
MeCP2 (methyl CpG binding protein 2) is known to suppress GFAP expression in vitro.

Purpose of the Study:

To investigate if reducing MeCP2 expression in the developing rat brain increases GFAP expression.
To determine if this effect is sex-specific and brain region-specific.
To explore the role of MeCP2 in regulating astrocyte markers.

Main Methods:

Infusion of MeCP2 or control siRNA into the amygdala of male and female rats during early postnatal development.
Analysis of GFAP mRNA and protein levels at 6 hours and 2 weeks post-infusion.
Assessment of other astrocyte markers (S100β, vimentin) to confirm specificity.

Main Results:

MeCP2 siRNA significantly increased GFAP mRNA and protein in the female amygdala on postnatal day 2.
This increase in GFAP was not observed in male rats.
GFAP levels returned to normal within two weeks, and other astrocyte markers remained unchanged.
Similar effects were observed in the hypothalamus, indicating a lack of strict brain region specificity.

Conclusions:

MeCP2 plays a specific role in suppressing GFAP expression in the developing female brain.
The function of MeCP2 appears to differ between developing male and female brains.
These findings contribute to understanding MeCP2 function, GFAP regulation, and the etiology of Rett syndrome.